ClinicalTrials.gg
Status unknownNCT04307160Updated Mar 13, 2020

Relationship of Age at Surgery to Surgical Outcome After Surgery for Intermittent Exotropia

An observational study in Intermittent Exotropia, sponsored by Cairo University. Status unknown. Per ClinicalTrials.gov, last updated 2020-03-13.

Sponsored by Cairo University · Observational

The sponsor has not verified this record recently (last verified Mar 2020), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
124
Sex
All
01

Study summary

It is prospective cohort study to compare ( the surgical outcome) the motor and sensory outcome of early surgery (≤5 years of age) and late surgery ( ≥ 7 years of age) for intermittent exotropia.

Read the detailed description

Sample Size:

One hundred and twenty four patients with intermittent exotropia will be included in this study in form of two groups based on the age at the first surgery; each group including 62 patients

  • Group I patients ≤ 5 years of age
  • Group II patients ≥ 7 years of age

Sample size calculation:

We are planning a study of independent cases and controls with 1 control(s) per case. Prior data indicate that the success rate among adults is 0.75. If the success rate for the young age group is 0.5, we will need to study 58 adult subjects and 58 young subjects to be able to reject the null hypothesis that the success rates for young and adult subjects are equal with probability (power) 0.8. The Type I error probability associated with this test of this null hypothesis is 0.05. We will use an uncorrected chi-squared statistic to evaluate this null hypothesis. Assuming a dropout rate of 5 %, a total of 62 patients will be recruited in each group.

Inclusion criteria:

All patients with intermittent exotropia in whom surgery is indicated

Exclusion criteria:

Patients with prior eye muscle surgery, restrictive or paralytic strabismus will be excluded. In addition, patients with craniofacial anomalies or neurological problems will be excluded from the study.

Methodology (in details):

A detailed history will be obtained including presence of asthenopia, monocular closure, disfigurement or diplopia. The previous use of glasses for optical correction, use of minus lenses, or prior part time occlusion will be documented.

A detailed ophthalmological examination; including corrected and uncorrected visual acuity whenever feasible, cycloplegic refraction, anterior segment examination and dilated fundus examination for any abnormalities.

Motor Evaluation:

Ductions and versions will be done to assess the ocular motility in all diagnositic positions of gaze.

The angle of misalignment will be measured by the prism and alternate cover tests for both distance and near. The angle will be measured without and with glasses. The angles of misalignment will also be measured in side gazes and in straight up and down gaze whenever possible. In patients with near distance disparity, the angle of deviation will be measured again after patching one eye for 30 minutes, as well as after putting +3 D lenses in front of each eye.

The control of exotropia will be assessed using both the newcastle control score and the new intermittent exotropia control scale designed by Mohney and Holmes.

Sensory Evaluation:

TNO stereo test, titmus fly test and worth 4 dot test for far will be done whenever possible.

Surgery:

All patients will undergo bilateral lateral rectus recession according to standard tables. In the younger age group, the amount of lateral rectus recession will be reduced by 0.5 mm. in those with inferior oblique overaction, inferior oblique recession will be performed.

Follow up and Evaluation:

Postoperatively, patients will be examined in the same preoperative manner after one week then after 6 weeks, 3 month and 6 months to assess the horizontal alignment and do sensory evaluation whenever possible.

Statistical analysis:

Data management and analysis will be performed using Statistical Package for Social Sciences (SPSS) version (21). Median and range for non-parametric measures and ordinal (scores) data. Numerical data will be presented as means ± standard deviations (SD). Categorical data will be presented as number and percentages %. Pairwise comparisons between the two groups for normally distributed variables will be done using the Student's t-test; the Mann-Whitney test, a nonparametric test equivalent to the t-test, will be used in non-normally distributed variables. The pre and postoperative data will be compared using repeated measures ANOVA, with Friedman's test as its non-parametric equivalent. The chi-square test or the Fisher's exact test will be used to compare between the groups with respect to categorical data. All p-values will be two-sided. P-values \< 0.05 will be considered significant.

02

Conditions studied

  • Intermittent Exotropia

Browse trials for

03

In context

Exotropia

58 studies on the registry are indexed under Exotropia; 13 are open to participants now.

Browse Exotropia studies →

Lead sponsor

Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

One hundred and twenty four patients with intermittent exotropia will be included in this study in form of two groups based on the age at the first surgery; each group including 62 patients

  • Group I patients ≤ 5 years of age
  • Group II patients ≥ 7 years of age Patients will be recruited from Kasr El Ainy and Cairo University Children Hospitals

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

All patients with intermittent exotropia in whom surgery is indicated

Exclusion criteria

Exclusion Criteria:

Patients with prior eye muscle surgery, restrictive or paralytic strabismus will be excluded. In addition, patients with craniofacial anomalies or neurological problems

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
124 participants (estimated)
Target follow-up
6 Months
Patient registry
Yes

Groups and cohorts

  • Group I

    Patients ≤ 5 years of age

    Procedure: Bilateral lateral rectus recession

  • Group II

    Patients ≥ 7 years of age

    Procedure: Bilateral lateral rectus recession

Interventions

  • ProcedureBilateral lateral rectus recession

    All patients will undergo bilateral lateral rectus recession according to standard tables. In the younger age group, the amount of lateral rectus recession will be reduced by 0.5 mm. in those with inferior oblique overaction, inferior oblique recession will be performed

06

What researchers measure

Primary outcomes

  1. Motor success rate

    Success rate defined as deviation between exotropia/phoria of 8 PD to esotropia/phoria of 4 PD

    Time frame: Six months

Secondary outcomes

  1. Change in stereoacuity

    Average log improvement of stereoacuity using TNO test at 6 months

    Time frame: Six months

  2. New misalignment

    Number of patients who developed underaction, or overaction of horizontal or oblique muscles

    Time frame: Six months

  3. Pattern deviation

    Number of patient who develop new A or V pattern after surgery.

    Time frame: Six months

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Buck D, Powell CJ, Sloper JJ, Taylor R, Tiffin P, Clarke MP; Improving Outcomes in Intermittent Exotropia (IOXT) Study group. Surgical intervention in childhood intermittent exotropia: current practice and clinical outcomes from an observational cohort study. Br J Ophthalmol. 2012 Oct;96(10):1291-5. doi: 10.1136/bjophthalmol-2012-301981. Epub 2012 Aug 11. PubMed 22887975 ↗
  • Richard JM, Parks MM. Intermittent exotropia. Surgical results in different age groups. Ophthalmology. 1983 Oct;90(10):1172-7. PubMed 6657192 ↗
  • Pratt-Johnson JA, Barlow JM, Tillson G. Early surgery in intermittent exotropia. Am J Ophthalmol. 1977 Nov;84(5):689-94. doi: 10.1016/0002-9394(77)90385-3. No abstract available. PubMed 930997 ↗
  • Haggerty H, Richardson S, Hrisos S, Strong NP, Clarke MP. The Newcastle Control Score: a new method of grading the severity of intermittent distance exotropia. Br J Ophthalmol. 2004 Feb;88(2):233-5. doi: 10.1136/bjo.2003.027615. PubMed 14736781 ↗
  • Abroms AD, Mohney BG, Rush DP, Parks MM, Tong PY. Timely surgery in intermittent and constant exotropia for superior sensory outcome. Am J Ophthalmol. 2001 Jan;131(1):111-6. doi: 10.1016/s0002-9394(00)00623-1. PubMed 11162985 ↗
  • Choi J, Kim SJ, Yu YS. Initial postoperative deviation as a predictor of long-term outcome after surgery for intermittent exotropia. J AAPOS. 2011 Jun;15(3):224-9. doi: 10.1016/j.jaapos.2010.12.019. Epub 2011 Jun 12. PubMed 21665502 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 13, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04307160
Lead sponsor
Cairo University
Responsible party
Ahmed Awadein (Professor of Ophthalmology, Cairo University) — Principal investigator
First posted
Mar 13, 2020
Start date
Apr 1, 2020 (estimated)
Primary completion
Dec 31, 2021 (estimated)
Completion
Jun 30, 2022 (estimated)
Last update
Mar 13, 2020

Study contacts

Ahmed R Awadein, MD
Contact
ahmedawadein@yahoo.com
00201223911743
Jylan A Gouda, MSc
Contact
gilangouda@yahoo.com
00201285430887
Ayman Elshiaty, MD
study director · Head of Ophthalmology Department, Cairo University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion